NDC 69448-021 – Osvyrti

Denosumab 60 mg/mL · Injection · Subcutaneous

Human Prescription Drug

Product NDC69448-021

Product details

Brand name
Osvyrti
Generic name
Denosumab-desu
Labeler
Accord BioPharma Inc.
Dosage form
Injection
Route
Subcutaneous
Marketing category
BLA · BLA761424
Marketed since
July 6, 2026
Listing expires
December 31, 2027
Pharmacologic class
RANK Ligand Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Osvyrti →

Package NDC codes (1)

Package NDCDescriptionSince
69448-021-631 SYRINGE in 1 CARTON (69448-021-63) / 1 mL in 1 SYRINGEJul 6, 2026